Detalles de la búsqueda
1.
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 650-658, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35421369
2.
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
Lancet Oncol
; 22(11): 1530-1540, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34656227
3.
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Lancet
; 396(10260): 1413-1421, 2020 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002429
4.
Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom.
BMC Cancer
; 21(1): 515, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33962574
5.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578639
6.
A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first-line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin.
BJU Int
; 126(2): 292-299, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32336008
7.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
; 392(10162): 2353-2366, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355464
8.
Performance status agreement assessed by the patient and clinician in a rapid access lung cancer service: Can either predict completion of treatment?
Eur J Cancer Care (Engl)
; 28(3): e13004, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30761639
9.
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial.
JAMA
; 322(21): 2084-2094, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31794625
10.
The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study.
Support Care Cancer
; 26(1): 119-127, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28721555
11.
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study.
PLoS Biol
; 12(7): e1001906, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25003521
12.
Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.
BMC Cancer
; 15: 544, 2015 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26204885
13.
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
Cochrane Database Syst Rev
; 1: CD002143, 2015 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25586198
14.
Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial.
EClinicalMedicine
; 52: 101595, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35990583
15.
Prognostic factors for survival and ambulatory status at 8 weeks with metastatic spinal cord compression in the SCORAD randomised trial.
Radiother Oncol
; 173: 77-83, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35618101
16.
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial.
EClinicalMedicine
; 48: 101432, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35706488
17.
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.
PLoS One
; 17(6): e0269192, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35653395
18.
Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Clash of the Generations.
Clin Lung Cancer
; 21(3): e216-e228, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32014348
19.
Chemotherapy decision-making in advanced lung cancer: a prospective qualitative study.
BMJ Support Palliat Care
; 2020 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32826262
20.
Assessment of contour variability in target volumes and organs at risk in lung cancer radiotherapy.
Tech Innov Patient Support Radiat Oncol
; 10: 8-12, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32095541